Lifecore Biomedical

LFCR · NASDAQ

$6.37−$0.02 (−0.31%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $6.39

Latest news

NewsOct 8, 4:17 AM ET
Lifecore Biomedical Q2 2026 Earnings Call Transcript
Press releaseOct 5, 10:40 PM ETPRNewswire
Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders?
Press releaseOct 3, 3:00 PM ETPRNewswire
EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- FWAC, MGLD, LFCR, and MG
NewsOct 2, 1:35 PM ETCaroline Ryan
Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankruptcy
Press releaseSep 30, 7:05 PM ETBusiness Wire
Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCR
Press releaseSep 29, 2:52 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR)
Press releaseSep 29, 1:53 PM ETPRNewswire
Are LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders?
Press releaseSep 28, 12:25 PM ETPRNewswire
LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC.
Press releaseSep 28, 11:39 AM ETBusiness Wire
LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders
NewsSep 28, 8:46 AM ET
Lifecore Biomedical To Be Acquired By Webster Equity Partners In Up To $663.7M Transaction; Stockholders May Receive Up To $9.67 Per Common Equivalent In Combined Cash And CVR At Full Performance Milestone Payments
Press releaseSep 28, 8:45 AM ETGlobe Newswire
Lifecore Biomedical to be Acquired by Webster Equity Partners
Press releaseSep 2, 7:05 AM ETGlobe Newswire
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
Press releaseAug 5, 7:05 AM ETGlobe Newswire
Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
Press releaseJul 28, 7:05 AM ETGlobe Newswire
Lifecore Biomedical Signs Three New Customer Agreements
Press releaseJun 15, 7:05 AM ETGlobe Newswire
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
NewsJun 2, 7:06 AM ET
Lifecore Biomedical Signs Manufacturing Services Agreement To Perform Process Development And Technical Transfer Services In Support Of Anticipated Commercial Manufacturing Upon Regulatory Approval
Press releaseJun 2, 7:05 AM ETGlobe Newswire
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
NewsMay 6, 8:58 AM ET
Lifecore Biomedical Q1 2026 Earnings Call Transcript
Press releaseMay 6, 7:05 AM ETGlobe Newswire
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
NewsMar 17, 8:42 AM ETVandana Singh
Lifecore Stock Sinks As Delayed Launches Push Growth Further Out
NewsMar 16, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
Press releaseMar 16, 8:00 AM ETGlobe Newswire
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
NewsMar 16, 7:11 AM ET
Earnings Scheduled For March 16, 2026
Press releaseJan 29, 5:09 PM ETPRNewswire
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Press releaseJan 15, 10:39 AM ETBusiness Wire
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Press releaseJan 9, 11:59 AM ETGlobe Newswire
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
Press releaseJan 8, 8:59 AM ETGlobe Newswire
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
Press releaseDec 24, 12:30 PM ETPRNewswire
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Press releaseDec 7, 2:49 PM ETBusiness Wire
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Press releaseNov 6, 4:05 PM ETGlobe Newswire
Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
NewsOct 29, 7:23 AM ET
Lifecore Expands CDMO Business, Becomes Supplier Of Choice For Leading Injectable Drug
Press releaseOct 29, 7:00 AM ETGlobe Newswire
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company
Press releaseSep 27, 8:31 AM ETGlobe Newswire
LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseAug 14, 8:42 PM ETGlobe Newswire
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseAug 7, 4:05 PM ETGlobe Newswire
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
NewsApr 4, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseApr 3, 4:05 PM ETGlobe Newswire
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
NewsJan 3, 6:42 AM ETRishabh Mishra
US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus
Press releaseSep 27, 10:51 AM ETBusiness Wire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Press releaseSep 26, 2:06 PM ETBusiness Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)
Press releaseSep 25, 6:47 PM ETPRNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit
Press releaseSep 25, 6:18 PM ETGlobe Newswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
Press releaseSep 25, 10:00 AM ETPRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lifecore Biomedical, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFCR
Press releaseSep 25, 8:30 AM ETPRNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Press releaseSep 24, 1:55 PM ETGlobe Newswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)
Press releaseSep 23, 10:40 AM ETPRNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
Press releaseSep 22, 9:00 PM ETGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Lifecore Biomedical Q2 2026 Earnings Call Transcript

Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders?

EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- FWAC, MGLD, LFCR, and MG

Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankruptcy

Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCR

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR)

Are LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders?

LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC.

LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders

Lifecore Biomedical To Be Acquired By Webster Equity Partners In Up To $663.7M Transaction; Stockholders May Receive Up To $9.67 Per Common Equivalent In Combined Cash And CVR At Full Performance Milestone Payments

Lifecore Biomedical to be Acquired by Webster Equity Partners

Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

Lifecore Biomedical Signs Three New Customer Agreements

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

Lifecore Biomedical Signs Manufacturing Services Agreement To Perform Process Development And Technical Transfer Services In Support Of Anticipated Commercial Manufacturing Upon Regulatory Approval

Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer

Earnings Scheduled For May 6, 2026

Lifecore Biomedical Q1 2026 Earnings Call Transcript

Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update

Lifecore Stock Sinks As Delayed Launches Push Growth Further Out

12 Health Care Stocks Moving In Monday's Intraday Session

Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update

Earnings Scheduled For March 16, 2026

HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf

HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update

Earnings Scheduled For November 6, 2025

Lifecore Expands CDMO Business, Becomes Supplier Of Choice For Leading Injectable Drug

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

12 Health Care Stocks Moving In Friday's Intraday Session

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lifecore Biomedical, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFCR

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm